k141_323608_1	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	50.0	792	764	1162	2.02e-245	714
k141_323608_1	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	47.1	797	764	1186	7.06e-234	685
k141_323608_1	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	47.1	797	764	1186	7.06e-234	685
k141_397179_2	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	31.4	223	241	293	4.93e-30	112
k141_632623_1	SARG|YP_002850805	26.8	470	539	652	2.61e-37	145
k141_632623_1	SARG|NP_348076	26.2	469	539	652	6.48e-37	144
k141_632623_1	SARG|CAA37477	26.5	510	539	663	1.72e-36	142
k141_632623_1	SARG|L20800.gene.p01	26.3	472	539	652	2.94e-36	142
k141_632623_1	SARG|ZP_02632674	26.2	484	539	660	5.63e-36	141
k141_632623_1	SARG|ZP_02952732	26.3	472	539	652	9.81e-36	140
k141_632623_1	NCBI|WP_063856408.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	26.5	464	539	654	3.31e-35	139
k141_632623_1	megares|MEG_7182|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	26.5	464	539	670	3.60e-35	139
k141_632623_1	SARG|AAB51122	26.5	464	539	670	3.60e-35	139
k141_632623_1	SARG|Q08425	26.5	464	539	641	5.58e-35	138
k141_515244_3	SARG|gi|499772320|ref|WP_011453054.1|	44.2	77	96	404	2.32e-15	68.6
k141_515244_3	SARG|gi|446136270|ref|WP_000214125.1|	45.5	77	96	404	4.34e-15	67.8
k141_515244_3	ResF|FloR_6_CP131474_1	45.5	77	96	404	4.34e-15	67.8
k141_515244_3	SARG|gi|742921897|ref|WP_039023559.1|	42.9	77	96	404	5.94e-15	67.4
k141_515244_3	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	44.3	79	96	411	5.99e-15	67.4
k141_515244_3	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	44.3	79	96	411	5.99e-15	67.4
k141_515244_3	SARG|D37826.1.gene1.p01	42.9	77	96	374	7.74e-15	67.0
k141_515244_3	SARG|AF261825.2.gene36.p01	42.9	77	96	404	8.13e-15	67.0
k141_515244_3	SARG|gi|505244440|ref|WP_015431542.1|	42.9	77	96	404	8.13e-15	67.0
k141_515244_3	SARG|gi|665823882|gb|AIF79467.1|	42.9	77	96	404	8.13e-15	67.0
k141_691669_6	NCBI|WP_049581834.1|1|1|dfrA45|dfrA45|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA45|AMR|diaminopyrimidine	43.9	164	160	164	1.57e-44	143
k141_691669_6	NCBI|WP_012655890.1|1|1|dfrE|dfrE|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrE|AMR|diaminopyrimidine	40.6	160	160	164	3.54e-38	127
k141_691669_6	SARG|gb|EOD99669.1|ARO:3002875|dfrE	42.1	164	160	164	1.85e-35	120
k141_691669_6	SARG|gb|AAA25550.1|ARO:3003105|dfrA3	37.3	161	160	162	4.95e-35	119
k141_691669_6	NCBI|WP_434062363.1|1|1|dfrA53|dfrA53|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA53|AMR|diaminopyrimidine	36.5	159	160	166	1.26e-33	115
k141_691669_6	SARG|gb|ABO40886.1|ARO:3004645|dfrI	40.6	143	160	191	8.84e-31	108
k141_691669_6	SARG|CAE53424	35.8	165	160	169	3.13e-26	96.7
k141_691669_6	NCBI|WP_204376219.1|1|1|dfrA25|dfrA25|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA25|AMR|diaminopyrimidine	36.1	158	160	157	4.59e-26	95.9
k141_691669_6	NCBI|WP_029391998.1|1|1|dfrA25|dfrA25|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA25|AMR|diaminopyrimidine	36.1	158	160	157	9.16e-26	95.1
k141_691669_6	megares|MEG_8066|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA_1	35.4	158	160	157	1.29e-25	94.7
k141_45486_1	SARG|YP_001373621	37.8	180	185	318	1.01e-36	128
k141_45486_1	SARG|ABB80128	37.9	177	185	306	1.55e-36	127
k141_45486_1	SARG|P42332	38.1	176	185	306	2.17e-36	127
k141_45486_1	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	38.1	176	185	306	2.17e-36	127
k141_45486_1	SARG|gi|445996719|ref|WP_000074574.1|	37.6	181	185	309	2.32e-36	127
k141_45486_1	SARG|gi|510143239|gb|AGN36970.1|	38.1	176	185	313	2.52e-36	127
k141_45486_1	SARG|gi|446110087|ref|WP_000187942.1|	37.3	185	185	309	3.26e-36	127
k141_45486_1	SARG|gi|445996710|ref|WP_000074565.1|	37.6	181	185	309	3.26e-36	127
k141_45486_1	SARG|gi|895736250|emb|COF64653.1|	37.0	181	185	309	1.27e-35	125
k141_45486_1	SARG|gi|445996714|ref|WP_000074569.1|	37.0	181	185	309	1.27e-35	125
k141_339354_2	ResF|penA_1_AF515059_1	31.3	552	657	581	1.05e-72	244
k141_119361_1	NCBI|WP_005480402.1|1|1|tet(35)|tet(35)|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_Na+/H+_antiporter_family_transporter_Tet(35)|AMR|tetracycline	28.6	234	245	533	4.05e-22	93.6
k141_119361_1	SARG|AF353562.gene.p01	27.4	234	245	369	2.97e-21	90.1
k141_325075_2	SARG|gb|AAC74000.1|ARO:3003950|msbA	36.4	571	595	582	3.63e-123	374
k141_325075_2	SARG|gi|860594225|ref|WP_048475168.1|	36.0	581	595	620	9.39e-114	351
k141_325075_2	SARG|gi|944152509|ref|WP_055644808.1|	35.7	575	595	616	3.30e-113	350
k141_325075_2	SARG|gi|944009777|ref|WP_055601444.1|	36.0	575	595	628	4.60e-113	350
k141_325075_2	SARG|gi|695842130|ref|WP_032755430.1|	36.4	566	595	603	9.05e-113	348
k141_325075_2	SARG|gi|505420018|ref|WP_015607120.1|	36.5	567	595	603	3.56e-112	347
k141_325075_2	SARG|gi|928900436|ref|WP_053931243.1|	36.6	566	595	600	1.29e-111	345
k141_325075_2	SARG|gi|664579989|ref|WP_031094015.1|	36.6	566	595	601	1.32e-111	345
k141_325075_2	SARG|gi|662129758|ref|WP_030081404.1|	35.9	566	595	605	2.08e-111	345
k141_325075_2	SARG|gi|664085850|ref|WP_030624018.1|	35.9	566	595	605	2.93e-111	344
k141_281159_1	SARG|gi|488231473|ref|WP_002302681.1|	29.0	193	346	492	2.93e-06	47.8
k141_281159_1	SARG|gi|488216250|ref|WP_002287458.1|	29.0	193	346	492	2.93e-06	47.8
k141_281159_1	SARG|gi|488247627|ref|WP_002318835.1|	29.0	193	346	492	2.93e-06	47.8
k141_281159_1	SARG|AY004350.gene.p01	29.0	193	346	492	2.93e-06	47.8
k141_281159_1	SARG|gi|488243106|ref|WP_002314314.1|	31.0	171	346	492	9.08e-06	46.2
k141_325630_2	SARG|AJ295238.gene.p01	41.3	155	266	639	1.11e-25	104
k141_325630_2	SARG|ABN79417	40.6	155	266	639	2.05e-25	103
k141_325630_2	megares|MEG_7177|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	40.6	155	266	639	2.78e-25	103
k141_325630_2	megares|MEG_7171|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	40.6	155	266	639	2.78e-25	103
k141_325630_2	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	40.6	155	266	629	3.73e-25	103
k141_325630_2	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	40.6	155	266	629	3.73e-25	103
k141_325630_2	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	40.6	155	266	629	3.73e-25	103
k141_325630_2	megares|MEG_7174|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	40.6	155	266	629	3.73e-25	103
k141_325630_2	NCBI|WP_013646121.1|1|1|tet(O/W/32/O)|tet(O/W/32/O)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_mosaic_protein_Tet(O/W/32/O)|AMR|tetracycline	40.6	155	266	639	3.77e-25	103
k141_325630_2	SARG|ABF69686	40.6	155	266	639	3.77e-25	103
k141_443878_1	SARG|gb|WP_104671188.1|ARO:3003948|efrA	27.0	403	400	575	1.00e-36	139
k141_443878_1	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	29.0	396	400	579	1.42e-36	139
k141_443878_1	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	29.4	378	400	579	2.67e-36	138
k141_443878_1	SARG|gb|AAC74000.1|ARO:3003950|msbA	26.8	365	400	582	5.75e-32	126
k141_443878_1	SARG|gi|764446018|ref|WP_044369325.1|	25.4	405	400	605	5.57e-31	123
k141_443878_1	SARG|gi|664458452|ref|WP_030980047.1|	26.4	401	400	601	1.01e-30	122
k141_443878_1	SARG|gi|695887424|ref|WP_032788534.1|	25.2	405	400	605	1.88e-30	122
k141_443878_1	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	27.3	352	400	574	2.19e-30	121
k141_443878_1	SARG|gi|497748188|ref|WP_010062372.1|	25.2	405	400	605	3.46e-30	121
k141_443878_1	SARG|gi|827013130|ref|WP_047175495.1|	25.6	403	400	603	4.66e-30	120
k141_32288_2	SARG|gi|694064328|ref|WP_032410816.1|	32.2	208	268	646	2.68e-21	92.0
k141_32288_2	SARG|gi|817122037|ref|WP_046494699.1|	29.6	226	268	613	3.28e-19	85.9
k141_32288_2	SARG|gi|930482089|ref|WP_054228897.1|	30.1	239	268	599	8.03e-19	84.7
k141_32288_2	SARG|gi|985844137|ref|WP_060895163.1|	30.1	239	268	599	8.03e-19	84.7
k141_32288_2	SARG|gi|953808775|ref|WP_058042812.1|	29.3	222	268	608	1.09e-18	84.3
k141_32288_2	SARG|gi|664556405|ref|WP_031071225.1|	28.7	223	268	602	3.63e-18	82.8
k141_32288_2	SARG|gb|AAK76137.1|ARO:3000024|patA	23.6	229	268	564	4.74e-18	82.4
k141_32288_2	SARG|gi|493394434|ref|WP_006350564.1|	29.0	231	268	602	6.62e-18	82.0
k141_32288_2	SARG|AF170880.4.gene1.p01	28.0	239	268	615	1.22e-17	81.3
k141_32288_2	SARG|gi|655401130|ref|WP_028800283.1|	28.8	222	268	599	1.63e-17	80.9
k141_91357_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.2	114	197	228	2.74e-15	70.5
k141_91357_3	CARD|gb|BAB36671.1|ARO:3000832|evgA	23.9	117	197	204	7.16e-06	43.9
k141_165056_2	SARG|AAD51059	35.2	250	504	323	1.26e-37	139
k141_165056_2	SARG|AAD41881	35.2	250	504	323	1.74e-37	139
k141_165056_2	SARG|AAR37059	35.3	249	504	323	2.40e-37	139
k141_165056_2	SARG|AAD42183	35.2	250	504	322	3.12e-36	135
k141_165056_2	SARG|YP_002333394	33.8	266	504	323	3.19e-36	135
k141_165056_2	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	33.8	266	504	323	3.19e-36	135
k141_165056_2	SARG|AF310956.2.gene5.p01	33.8	266	504	323	4.41e-36	135
k141_165056_2	SARG|gb|AAB05626.1|ARO:3002943|vanHB	33.8	266	504	323	1.16e-35	134
k141_165056_2	SARG|Q47748	33.5	266	504	323	3.05e-35	133
k141_165056_2	SARG|gi|498515089|ref|WP_010815296.1|	33.5	266	504	323	4.21e-35	132
k141_312316_2	SARG|AE016830.1.gene424.p01	26.8	239	274	505	2.23e-17	80.5
k141_459376_2	SARG|AF226276.1.gene3.p01	46.1	206	210	207	1.11e-69	210
k141_459376_2	SARG|X15100.gene.p01	46.3	205	210	212	5.29e-69	209
k141_459376_2	SARG|S48276.1.gene1.p01	42.9	205	210	216	4.55e-66	201
k141_459376_2	NCBI|WP_043774378.1|1|1|catA13|catA13|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_A-13_phenicol_O-acetyltransferase|AMR|phenicol	41.7	206	210	207	2.78e-65	199
k141_459376_2	SARG|YP_001144149	41.7	206	210	208	2.87e-65	199
k141_459376_2	SARG|M35190.gene.p01	40.3	206	210	207	3.67e-63	194
k141_459376_2	SARG|gi|505206451|ref|WP_015393553.1|	41.3	208	210	219	6.50e-59	183
k141_459376_2	NCBI|WP_063843221.1|1|1|catA16|catA16|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_A-16_phenicol_O-acetyltransferase_CatQ|AMR|phenicol	40.6	212	210	219	6.50e-59	183
k141_459376_2	SARG|YP_001310303	40.4	213	210	219	9.21e-59	183
k141_459376_2	ResF|catS_1_X74948_1	47.5	177	210	178	2.95e-58	180
k141_650815_4	SARG|gi|446048013|ref|WP_000125868.1|	29.3	215	490	648	6.04e-22	98.2
k141_650815_4	SARG|gi|488130770|ref|WP_002201978.1|	30.0	227	490	309	2.05e-16	79.0
k141_650815_4	SARG|gi|447057509|ref|WP_001134765.1|	29.6	203	490	309	1.22e-15	76.6
k141_650815_4	SARG|gi|488068784|ref|WP_002140181.1|	29.6	203	490	309	1.22e-15	76.6
k141_650815_4	SARG|gi|488067981|ref|WP_002139378.1|	29.6	203	490	309	1.64e-15	76.3
k141_650815_4	SARG|gi|507023808|ref|WP_016095885.1|	29.6	203	490	309	1.64e-15	76.3
k141_650815_4	SARG|gi|487936534|ref|WP_002010000.1|	29.6	203	490	309	1.64e-15	76.3
k141_650815_4	SARG|gi|488120365|ref|WP_002191762.1|	29.6	203	490	309	2.20e-15	75.9
k141_650815_4	SARG|gi|507055561|ref|WP_016126482.1|	28.6	203	490	309	2.96e-15	75.5
k141_650815_4	SARG|gi|507050365|ref|WP_016121371.1|	29.1	203	490	309	5.35e-15	74.7
k141_33800_1	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	37.1	170	339	343	2.45e-31	119
k141_33800_1	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	36.5	167	339	325	1.25e-29	114
k141_33800_1	SARG|gb|AAA26793|ARO:3003748|oleC	36.5	167	339	325	2.41e-29	114
k141_33800_1	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	37.0	146	339	293	4.53e-25	101
k141_33800_1	SARG|gb|CDO61516.1|ARO:3003949|efrB	32.9	155	339	362	5.21e-16	77.0
k141_33800_1	SARG|gb|AAR96051.1|ARO:3002894|otrC	31.5	178	339	351	6.54e-16	76.6
k141_33800_1	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	30.9	178	339	351	3.98e-15	74.3
k141_592202_2	CARD|gb|WKR28567.1|ARO:3007678|IreK	36.2	602	619	718	5.91e-94	303
k141_107382_4	SARG|YP_002333394	26.0	250	324	323	1.10e-15	75.5
k141_107382_4	SARG|AF310956.2.gene5.p01	25.6	250	324	323	3.72e-15	73.9
k141_107382_4	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	25.6	250	324	323	3.72e-15	73.9
k141_107382_4	SARG|gi|498515089|ref|WP_010815296.1|	26.5	215	324	323	5.05e-15	73.6
k141_107382_4	SARG|Q47748	26.5	215	324	323	6.84e-15	73.2
k141_107382_4	SARG|gi|985522333|ref|WP_060811962.1|	26.5	215	324	323	6.84e-15	73.2
k141_107382_4	SARG|gb|AAB05626.1|ARO:3002943|vanHB	26.0	215	324	323	4.20e-14	70.9
k141_78126_2	SARG|AXF35727.1	21.7	217	262	497	8.76e-06	45.4
k141_19634_7	NCBI|WP_005813024.1|1|1|vanW-I|vanW-I||2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_accessory_protein_VanW-I|AMR|glycopeptide	35.7	227	436	373	5.88e-30	118
k141_592596_3	SARG|gb|ABA71733.1|ARO:3002972|vanTG	33.7	359	367	712	1.97e-53	186
k141_592596_3	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	33.6	375	367	712	2.10e-48	172
k141_592596_3	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	34.3	362	367	711	1.03e-47	171
k141_592596_3	SARG|FJ872411.1.gene43.p01	26.4	364	367	702	4.01e-31	123
k141_299133_1	SARG|gb|ADO96486.1|ARO:3003953|hmrM	32.4	176	180	464	1.79e-16	75.1
k141_299133_1	NCBI|AAC23256.1|1|1|hmrM|hmrM|efflux|1|EFFLUX|EFFLUX|sodium-coupled_multidrug_efflux_MATE_transporter_HmrM|AMR|efflux	32.4	176	180	464	2.44e-16	74.7
k141_299133_1	SARG|gb|BAD89844.2|ARO:3000753|abeM	39.1	92	180	448	7.08e-15	70.5
k141_299133_1	SARG|gb|AAG04750.1|ARO:3004077|PmpM	28.2	177	180	477	7.06e-11	58.9
k141_299133_1	SARG|gi|555038129|gb|ESL82444.1|	40.0	85	180	453	9.42e-11	58.5
k141_299133_1	SARG|gi|635778884|gb|KDF60313.1|	40.0	85	180	453	9.42e-11	58.5
k141_299133_1	SARG|gi|555211913|gb|ESN54240.1|	40.0	85	180	453	9.42e-11	58.5
k141_299133_1	SARG|gi|555139174|gb|ESM81938.1|	40.0	85	180	453	9.42e-11	58.5
k141_299133_1	SARG|gi|578204972|gb|EUL65205.1|	40.0	85	180	453	1.28e-10	58.2
k141_299133_1	SARG|gi|578248426|gb|EUM08518.1|	38.8	85	180	453	1.28e-10	58.2
k141_563737_1	SARG|gb|AAK76136.1|ARO:3000025|patB	25.8	524	554	588	6.47e-39	149
k141_563737_1	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	24.4	516	554	579	2.02e-38	147
k141_563737_1	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	25.3	505	554	579	1.74e-37	145
k141_563737_1	SARG|gb|AYV52072.1|ARO:3002882|lmrD	25.3	475	554	664	5.18e-36	141
k141_563737_1	SARG|gb|CDO61516.1|ARO:3003949|efrB	28.6	262	554	362	8.10e-29	116
k141_49631_2	SARG|gi|445996709|ref|WP_000074564.1|	29.1	182	223	309	4.69e-22	90.9
k141_49631_2	SARG|gi|445996723|ref|WP_000074578.1|	28.0	193	223	309	3.32e-21	88.6
k141_49631_2	SARG|gi|507035724|ref|WP_016107411.1|	27.5	193	223	309	4.60e-21	88.2
k141_49631_2	SARG|gi|445996698|ref|WP_000074553.1|	27.5	193	223	309	4.60e-21	88.2
k141_49631_2	SARG|gi|445996710|ref|WP_000074565.1|	28.6	182	223	309	4.60e-21	88.2
k141_49631_2	SARG|gi|445996722|ref|WP_000074577.1|	28.0	193	223	309	4.60e-21	88.2
k141_49631_2	SARG|gi|445996697|ref|WP_000074552.1|	27.5	193	223	309	6.37e-21	87.8
k141_49631_2	SARG|gi|445996696|ref|WP_000074551.1|	27.5	193	223	309	6.37e-21	87.8
k141_49631_2	SARG|gi|814314593|emb|CKF49145.1|	28.6	182	223	309	6.37e-21	87.8
k141_49631_2	SARG|gi|1043490477|ref|WP_065382463.1|	27.5	193	223	309	8.82e-21	87.4
k141_49755_1	SARG|YP_001445425	34.7	300	411	456	2.57e-44	159
k141_49755_1	SARG|gb|AAG04750.1|ARO:3004077|PmpM	34.0	300	411	477	1.36e-42	154
k141_49755_1	SARG|gi|754952496|ref|WP_042308660.1|	33.2	292	411	457	1.86e-42	154
k141_49755_1	SARG|gi|1002398650|ref|WP_061381408.1|	33.2	292	411	457	1.86e-42	154
k141_49755_1	SARG|gi|695797326|ref|WP_032711517.1|	34.6	280	411	457	3.59e-42	153
k141_49755_1	SARG|gi|491269060|ref|WP_005127195.1|	33.2	292	411	457	4.97e-42	152
k141_49755_1	SARG|NP_934523	33.8	302	411	456	6.78e-42	152
k141_49755_1	SARG|gi|487511179|ref|WP_001706772.1|	33.6	292	411	457	9.56e-42	152
k141_49755_1	SARG|gi|757799242|ref|WP_043016444.1|	33.2	292	411	457	9.56e-42	152
k141_49755_1	SARG|gi|851901342|ref|WP_048211771.1|	33.2	292	411	457	1.33e-41	151
k141_137595_1	SARG|AUI09862.1	43.0	277	290	287	2.85e-65	205
k141_137595_1	SARG|AJ459418.gene.p01	35.7	266	290	263	3.38e-48	160
k141_137595_1	SARG|gi|970263436|ref|WP_058647620.1|	35.7	266	290	263	6.71e-48	159
k141_137595_1	SARG|gi|486033774|ref|WP_001505252.1|	35.0	263	290	271	2.57e-46	155
k141_137595_1	SARG|gi|490067892|ref|WP_003970071.1|	35.0	263	290	271	5.09e-46	155
k141_137595_1	SARG|gi|728806562|ref|WP_033917658.1|	35.0	263	290	271	7.17e-46	154
k141_137595_1	SARG|gi|754661150|ref|WP_042043527.1|	34.6	263	290	271	2.82e-45	153
k141_137595_1	SARG|gi|550552396|ref|WP_022631488.1|	35.0	263	290	271	2.82e-45	153
k141_137595_1	NCBI|WP_001043265.1|1|1|sul2|sul2|insensitivity|2|sulfonamide|sulfonamide|sulfonamide-resistant_dihydropteroate_synthase_Sul2|AMR|sulfonamide	34.6	263	290	271	3.97e-45	152
k141_137595_1	SARG|gi|916164813|ref|WP_050960181.1|	34.6	263	290	271	3.97e-45	152
k141_667518_4	SARG|gb|AAV85982.1|ARO:3000535|macB	41.0	205	229	644	1.33e-43	154
k141_667518_4	SARG|M80346.gene.p01	29.2	195	229	551	2.01e-18	82.4
k141_667518_4	megares|MEG_1491|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|CARA_1	29.2	195	229	551	2.01e-18	82.4
k141_667518_4	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	38.5	78	229	568	1.21e-09	56.6
k141_667518_4	SARG|KC539823.1.gene1.p01	37.1	97	229	522	5.20e-09	54.7
k141_667518_4	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	37.1	97	229	522	7.00e-09	54.3
k141_667518_4	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	32.7	98	229	550	7.13e-09	54.3
k141_667518_4	NCBI|WP_032492560.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	36.1	97	229	522	2.29e-08	52.8
k141_667518_4	SARG|DQ823382.1.gene1.p01	36.1	97	229	522	2.29e-08	52.8
k141_667518_4	megares|MEG_7687|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	36.1	97	229	522	2.29e-08	52.8
k141_94156_1	SARG|CP003583.1.gene510.p01	38.9	386	396	457	2.64e-91	281
k141_94156_1	SARG|gi|498485855|ref|WP_010787543.1|	31.6	389	396	476	2.19e-60	201
k141_94156_1	SARG|AE016830.1.gene424.p01	32.8	354	396	505	8.07e-60	201
k141_94156_1	SARG|gi|503878543|ref|WP_014112537.1|	31.4	389	396	477	4.66e-59	198
k141_94156_1	SARG|gi|542004148|gb|ERH50104.1|	33.8	358	396	477	2.50e-58	196
k141_94156_1	SARG|gi|631799622|gb|AHZ14287.1|	31.6	389	396	477	3.51e-58	196
k141_94156_1	SARG|gi|1007411670|gb|AMQ72759.1|	33.8	358	396	477	3.51e-58	196
k141_94156_1	SARG|gi|1030030526|gb|ANF35167.1|	33.8	358	396	477	4.91e-58	195
k141_94156_1	SARG|YP_001419928	33.8	358	396	477	4.91e-58	195
k141_94156_1	SARG|gi|371566923|emb|CCF03773.1|	34.5	333	396	477	6.87e-58	195
k141_417998_3	NCBI|PBI24747.1|1|1|vanG-Cd|vanG-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|D-alanine--D-serine_ligase_VanG-Cd|AMR|glycopeptide	32.2	270	312	366	1.86e-37	135
k141_417998_3	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_5	33.5	257	312	281	3.12e-37	133
k141_417998_3	SARG|gi|1028100561|ref|WP_063856696.1|	34.0	247	312	349	5.05e-37	134
k141_417998_3	NCBI|WP_018211347.1|1|1|vanI|vanI|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-alanine--(R)-lactate_ligase_VanI|AMR|glycopeptide	30.1	339	312	345	9.09e-37	133
k141_417998_3	SARG|DQ212986.1.gene8.p01	33.6	247	312	349	3.74e-36	132
k141_417998_3	SARG|gi|405945042|pdb|4FU0|A	33.6	247	312	357	4.36e-36	132
k141_417998_3	SARG|gi|752682279|ref|WP_041330231.1|	33.2	247	312	349	1.01e-35	130
k141_417998_3	SARG|gi|765411304|ref|WP_044689514.1|	33.6	247	312	349	1.01e-35	130
k141_417998_3	SARG|AAF71281	33.2	247	312	349	1.97e-35	130
k141_417998_3	SARG|gi|726976857|ref|WP_033582037.1|	32.1	271	312	340	2.31e-35	129
k141_64896_3	SARG|gi|542061059|gb|ERI11611.1|	30.1	226	289	316	2.60e-28	109
k141_64896_3	SARG|gi|938460528|ref|WP_054624864.1|	31.4	239	289	647	4.83e-25	103
k141_64896_3	SARG|gi|504542119|ref|WP_014729221.1|	30.4	257	289	647	1.20e-24	102
k141_64896_3	SARG|gi|938461734|ref|WP_054625806.1|	31.0	239	289	647	2.98e-24	101
k141_64896_3	SARG|gi|1020141879|ref|WP_063264839.1|	31.0	239	289	647	2.98e-24	101
k141_64896_3	SARG|gi|490522515|ref|WP_004387938.1|	31.0	239	289	647	2.98e-24	101
k141_64896_3	SARG|gi|655997348|ref|WP_029038923.1|	31.0	239	289	647	2.98e-24	101
k141_64896_3	SARG|gi|426326769|emb|CCK10228.1|	31.0	239	289	648	2.98e-24	101
k141_64896_3	SARG|YP_001438541	31.9	210	289	647	4.04e-24	100
k141_64896_3	SARG|gb|AAV85982.1|ARO:3000535|macB	33.8	207	289	644	5.45e-24	100
k141_579789_2	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	36.7	461	460	451	7.41e-89	277
k141_579789_2	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	36.9	461	460	481	2.67e-87	274
k141_579789_2	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	37.6	460	460	451	9.05e-87	271
k141_653449_2	SARG|CP000768.1.gene1024.p01	27.9	394	366	390	7.61e-28	111
k141_653449_2	SARG|gi|488899926|ref|WP_002811019.1|	27.9	398	366	385	1.14e-25	105
k141_653449_2	SARG|gi|488868725|ref|WP_002780964.1|	27.6	398	366	385	4.01e-25	103
k141_653449_2	SARG|gi|488872078|ref|WP_002784303.1|	27.6	398	366	385	5.49e-25	103
k141_653449_2	SARG|gi|533111866|ref|WP_020975044.1|	28.4	391	366	390	5.20e-24	100
k141_653449_2	SARG|gi|489018151|ref|WP_002928665.1|	33.2	199	366	380	4.14e-23	98.2
k141_653449_2	SARG|gi|488995429|ref|WP_002906142.1|	27.1	402	366	390	1.17e-22	97.1
k141_653449_2	SARG|gi|315927342|gb|EFV06686.1|	36.4	220	366	331	7.19e-22	94.0
k141_653449_2	SARG|gi|488963196|ref|WP_002874220.1|	36.4	220	366	390	7.45e-22	94.7
k141_653449_2	SARG|gi|489021473|ref|WP_002931964.1|	34.1	220	366	390	7.45e-22	94.7
k141_653449_3	SARG|gi|835330218|ref|WP_047457825.1|	50.2	221	237	648	1.31e-69	224
k141_653449_3	SARG|YP_001453760	50.2	221	237	648	1.31e-69	224
k141_653449_3	SARG|gi|740856590|ref|WP_038641842.1|	49.3	227	237	648	1.31e-69	224
k141_653449_3	SARG|gi|754951242|ref|WP_042307417.1|	49.3	227	237	648	1.84e-69	223
k141_653449_3	SARG|gi|493734654|ref|WP_006683876.1|	49.3	227	237	648	1.84e-69	223
k141_653449_3	SARG|gi|696368937|ref|WP_032943949.1|	49.3	227	237	648	2.57e-69	223
k141_653449_3	SARG|gi|851913025|ref|WP_048215946.1|	49.3	227	237	648	2.57e-69	223
k141_653449_3	SARG|gi|489930965|ref|WP_003834285.1|	49.3	227	237	648	2.57e-69	223
k141_653449_3	SARG|gi|696361545|ref|WP_032936694.1|	49.3	227	237	648	3.60e-69	223
k141_653449_3	SARG|gi|489936909|ref|WP_003840216.1|	49.3	227	237	648	3.60e-69	223
k141_653449_4	SARG|gb|AAV85982.1|ARO:3000535|macB	38.8	399	405	644	8.15e-75	244
k141_653449_4	SARG|gi|639209604|ref|WP_024547784.1|	39.2	401	405	648	4.06e-70	231
k141_653449_4	SARG|YP_001438541	38.8	405	405	647	2.96e-69	229
k141_653449_4	SARG|gi|938460528|ref|WP_054624864.1|	38.8	405	405	647	2.96e-69	229
k141_653449_4	SARG|gi|490522515|ref|WP_004387938.1|	38.8	405	405	647	2.96e-69	229
k141_653449_4	SARG|gi|696420214|ref|WP_032990021.1|	38.8	405	405	647	2.96e-69	229
k141_653449_4	SARG|gi|506220920|ref|WP_015740695.1|	38.8	405	405	647	4.14e-69	229
k141_653449_4	SARG|gi|938461734|ref|WP_054625806.1|	38.8	405	405	647	5.78e-69	228
k141_653449_4	SARG|gi|495004199|ref|WP_007730213.1|	38.5	405	405	647	5.78e-69	228
k141_653449_4	SARG|gi|742384718|ref|WP_038863845.1|	39.2	411	405	647	5.78e-69	228
k141_550358_1	NCBI|WP_087348261.1|1|1|rphD|rphD||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphD|AMR|rifamycin	40.9	323	564	872	2.17e-62	219
k141_550358_1	NCBI|WP_087347987.1|1|1|rphC|rphC||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphC|AMR|rifamycin	39.6	321	564	868	4.95e-61	215
k141_550358_1	SARG|gb|APB03222.1|ARO:3003992|rphB	40.0	320	564	884	3.41e-59	210
k141_550358_1	SARG|gb|AIA08936.1|ARO:3000444|rphA	37.5	307	564	865	1.64e-54	197
k141_389226_5	SARG|gb|AAV85982.1|ARO:3000535|macB	29.5	129	137	644	2.45e-09	53.1
k141_95246_1	megares|MEG_6058|Drugs|MLS|23S_rRNA_methyltransferases|RLMH_1	53.2	47	51	159	1.82e-11	53.9
k141_95246_5	CARD|gb|AAN28945.1|ARO:3003785|Ctra_murA_FOF	34.4	279	288	444	1.19e-44	155
k141_315796_1	SARG|gi|694089948|ref|WP_032434648.1|	20.0	406	411	457	7.17e-07	50.1
k141_550754_1	SARG|YP_607927	30.3	386	370	1059	1.63e-44	163
k141_550754_1	SARG|gi|497896441|ref|WP_010210597.1|	29.9	384	370	1059	2.99e-44	162
k141_550754_1	SARG|gi|655279967|ref|WP_028689378.1|	30.1	386	370	1059	4.05e-44	162
k141_550754_1	SARG|gi|512743205|ref|WP_016499908.1|	29.4	384	370	1059	5.49e-44	161
k141_550754_1	SARG|NP_745564	29.4	384	370	1059	5.49e-44	161
k141_550754_1	SARG|YP_001668745	29.4	384	370	1059	5.49e-44	161
k141_550754_1	SARG|CAY49157	29.7	384	370	1059	5.49e-44	161
k141_550754_1	SARG|YP_001749316	29.4	384	370	1059	7.45e-44	161
k141_550754_1	SARG|gi|1044868049|dbj|BAV27457.1|	29.4	384	370	1058	1.01e-43	160
k141_550754_1	SARG|gi|504907940|ref|WP_015095042.1|	29.4	384	370	1059	1.01e-43	160
k141_448337_1	SARG|gi|515606615|ref|WP_017039215.1|	26.5	204	461	436	1.18e-07	52.8
k141_448337_1	SARG|gi|515602945|ref|WP_017035545.1|	26.5	204	461	436	1.18e-07	52.8
k141_448337_1	SARG|gi|922032953|ref|WP_053310753.1|	26.8	183	461	437	1.96e-06	48.9
k141_448337_1	SARG|gi|724471628|gb|AIY26267.1|	26.8	183	461	437	1.96e-06	48.9
k141_448337_1	SARG|gi|692125167|ref|WP_032081234.1|	25.3	174	461	439	6.04e-06	47.4
k141_448337_1	SARG|gi|764440891|ref|WP_044366757.1|	25.3	174	461	439	6.04e-06	47.4
k141_301351_4	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.7	221	227	219	1.65e-50	162
k141_301351_4	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.1	218	227	219	2.90e-36	126
k141_301351_4	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.1	218	227	220	2.98e-36	126
k141_301351_4	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.6	218	227	220	2.98e-36	126
k141_301351_4	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	33.8	219	227	225	3.39e-36	126
k141_301351_4	CARD|gb|AAC73788.1|ARO:3003841|kdpE	33.8	219	227	225	3.39e-36	126
k141_301351_4	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.1	218	227	220	8.33e-36	125
k141_301351_4	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.7	218	227	219	2.27e-35	124
k141_301351_4	SARG|ZP_02848503	32.1	218	227	221	2.25e-32	116
k141_301351_4	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	29.8	218	227	223	2.02e-25	98.2
k141_301351_6	SARG|P45439	28.6	192	208	319	5.78e-08	50.8
k141_301351_6	megares|MEG_2845|Drugs|MLS|23S_rRNA_methyltransferases|ERMS_1	28.6	192	208	319	5.78e-08	50.8
k141_522857_1	SARG|gi|542061059|gb|ERI11611.1|	29.1	175	227	316	1.25e-17	79.0
k141_522857_1	SARG|gi|445996719|ref|WP_000074574.1|	29.7	172	227	309	5.77e-17	77.0
k141_522857_1	SARG|gi|445996710|ref|WP_000074565.1|	29.1	175	227	309	7.93e-17	76.6
k141_522857_1	SARG|gi|488120365|ref|WP_002191762.1|	29.7	175	227	309	1.09e-16	76.3
k141_522857_1	SARG|gi|507023808|ref|WP_016095885.1|	29.1	172	227	309	1.09e-16	76.3
k141_522857_1	SARG|gi|447057509|ref|WP_001134765.1|	29.1	175	227	309	1.09e-16	76.3
k141_522857_1	SARG|gi|447057510|ref|WP_001134766.1|	29.1	175	227	309	1.09e-16	76.3
k141_522857_1	SARG|gi|507055561|ref|WP_016126482.1|	29.1	172	227	309	1.50e-16	75.9
k141_522857_1	SARG|gi|488068784|ref|WP_002140181.1|	29.1	175	227	309	1.50e-16	75.9
k141_522857_1	SARG|gi|488067981|ref|WP_002139378.1|	29.1	175	227	309	2.83e-16	75.1
k141_522859_2	SARG|ZP_03225116	48.4	256	266	263	1.11e-79	240
k141_522859_2	SARG|YP_001140148	51.9	262	266	271	1.32e-77	235
k141_522859_2	SARG|YP_001644180	50.0	258	266	263	4.14e-77	233
k141_522859_2	SARG|YP_001436495	50.0	264	266	272	7.79e-77	233
k141_522859_2	SARG|ZP_04167983	49.6	258	266	263	1.67e-76	232
k141_522859_2	SARG|ZP_04196507	49.6	258	266	263	1.67e-76	232
k141_522859_2	SARG|YP_312012	48.3	271	266	273	3.23e-76	231
k141_522859_2	SARG|ZP_04202328	50.8	260	266	263	3.34e-76	231
k141_522859_2	SARG|ZP_04310898	49.6	258	266	263	3.34e-76	231
k141_522859_2	SARG|gi|324115360|gb|EGC09324.1|	48.3	271	266	270	4.17e-76	231
k141_345558_2	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	63.7	402	495	1162	3.54e-167	501
k141_345558_2	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	61.3	419	495	1186	2.38e-162	489
k141_345558_2	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	61.3	419	495	1186	2.38e-162	489
k141_37172_1	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	25.8	287	641	1024	2.08e-14	75.9
k141_37172_1	SARG|gb|CAA53189|ARO:3000521|mupA	25.8	287	641	1024	2.08e-14	75.9
k141_37172_1	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	25.8	287	641	1024	6.27e-14	74.3
k141_37172_1	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	25.8	287	641	1024	6.27e-14	74.3
k141_37172_1	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	26.6	222	641	1033	3.13e-10	62.4
k141_37172_1	SARG|gb|AEY83581|ARO:3000510|mupB	26.6	222	641	1033	3.13e-10	62.4
k141_360919_1	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.0	221	617	381	1.20e-25	108
k141_360919_1	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.0	221	617	381	1.20e-25	108
k141_360919_1	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	27.6	221	617	381	5.35e-25	106
k141_360919_1	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	27.6	221	617	381	5.35e-25	106
k141_360919_1	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	26.8	213	617	370	8.33e-21	93.6
k141_360919_1	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	25.4	248	617	365	2.56e-20	92.0
k141_37627_1	SARG|gb|ACJ63262.1|ARO:3003107|mefB	23.3	348	406	409	9.58e-15	74.3
k141_37627_1	megares|MEG_3826|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFA_1	23.2	392	406	405	1.71e-11	64.3
k141_37627_1	SARG|AAY68306	23.3	361	406	405	5.40e-11	62.8
k141_37627_1	SARG|gi|755004067|ref|WP_042357457.1|	22.5	355	406	408	9.65e-11	62.0
k141_37627_1	SARG|gi|912688367|ref|WP_050233077.1|	21.9	388	406	405	1.27e-10	61.6
k141_37627_1	SARG|CAG30572	22.7	374	406	405	1.27e-10	61.6
k141_37627_1	SARG|gi|912742537|ref|WP_050255874.1|	21.9	388	406	405	1.69e-10	61.2
k141_37627_1	SARG|ABC60093	22.7	370	406	405	3.00e-10	60.5
k141_37627_1	SARG|ACG58975	22.4	357	406	405	3.00e-10	60.5
k141_37627_1	SARG|AAQ62546	22.7	370	406	405	3.99e-10	60.1
k141_185148_5	SARG|YP_002850060	40.0	210	209	648	1.49e-39	142
k141_185148_5	SARG|gi|696368937|ref|WP_032943949.1|	40.0	210	209	648	2.05e-39	141
k141_185148_5	SARG|gi|851913025|ref|WP_048215946.1|	40.0	210	209	648	2.05e-39	141
k141_185148_5	SARG|gi|489930965|ref|WP_003834285.1|	40.0	210	209	648	2.05e-39	141
k141_185148_5	SARG|gi|740610794|ref|WP_038396317.1|	40.0	210	209	648	2.05e-39	141
k141_185148_5	SARG|gi|696361545|ref|WP_032936694.1|	40.0	210	209	648	2.82e-39	141
k141_185148_5	SARG|gi|489936909|ref|WP_003840216.1|	40.0	210	209	648	2.82e-39	141
k141_185148_5	SARG|gi|507079862|ref|WP_016150620.1|	40.0	210	209	648	2.82e-39	141
k141_185148_5	SARG|gi|949791377|ref|WP_057104572.1|	40.0	210	209	648	2.82e-39	141
k141_185148_5	SARG|gi|936194420|ref|WP_054528571.1|	40.0	210	209	648	3.88e-39	140
k141_405557_1	SARG|gb|AAV85982.1|ARO:3000535|macB	35.0	226	254	644	3.80e-29	114
k141_405557_1	SARG|gi|671541568|ref|WP_031525212.1|	31.9	213	254	648	1.43e-21	92.4
k141_405557_1	SARG|gb|AGN74946|ARO:3003749|salA	25.7	179	254	541	7.92e-08	51.6
k141_405557_1	ResF|poxtA-Ef_1_WP094899500.1_1	24.6	207	254	538	8.16e-07	48.5
k141_405557_1	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	24.6	207	254	543	8.19e-07	48.5
k141_405557_1	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	24.6	207	254	543	8.19e-07	48.5
k141_581788_3	SARG|gb|BAG33043.1|ARO:3003920|pgpB	25.6	176	195	236	7.30e-07	47.0
k141_581788_3	megares|MEG_5776|Drugs|Lipopeptide|Lipid_A_phosphatase|PGBB_1	25.6	176	195	236	7.30e-07	47.0
k141_317929_2	SARG|B7LM76	32.4	272	314	660	6.60e-41	149
k141_317929_2	SARG|gi|757781454|ref|WP_043000038.1|	32.3	279	314	660	1.25e-40	149
k141_317929_2	SARG|gi|507086291|ref|WP_016157032.1|	33.1	272	314	660	4.42e-40	147
k141_317929_2	SARG|gi|851928593|ref|WP_048220996.1|	32.7	272	314	660	6.07e-40	147
k141_317929_2	SARG|gi|735685540|ref|WP_034173220.1|	33.0	276	314	660	6.07e-40	147
k141_317929_2	SARG|gi|693074684|ref|WP_032237896.1|	33.0	276	314	660	6.07e-40	147
k141_317929_2	SARG|gi|486385683|ref|WP_001600222.1|	33.0	276	314	660	6.07e-40	147
k141_317929_2	SARG|ZP_02901868	32.0	272	314	660	6.07e-40	147
k141_317929_2	SARG|gi|486392102|ref|WP_001603016.1|	33.0	276	314	660	6.07e-40	147
k141_317929_2	SARG|gi|754613472|ref|WP_042002901.1|	33.0	276	314	660	8.32e-40	146
k141_23717_2	CARD|gb|AAG03547.1|ARO:3003680|TriB	26.6	342	355	356	1.92e-27	109
k141_23717_2	CARD|gb|AAC75135.2|ARO:3000792|mdtA	26.6	293	355	415	5.79e-22	95.1
k141_23717_3	SARG|gb|AAG07064.1|ARO:3003693|mexK	39.6	1024	1048	1025	5.02e-254	742
k141_23717_3	CARD|gb|AAG03548.1|ARO:3003681|TriC	38.3	1014	1048	1015	8.05e-244	716
k141_23717_3	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	24.1	1040	1048	1074	4.77e-61	226
k141_23717_3	SARG|gi|499256187|ref|WP_010953727.1|	24.8	1041	1048	1042	1.71e-60	224
k141_23717_3	SARG|YP_348389	24.0	1039	1048	1063	4.57e-60	223
k141_23717_3	NCBI|WP_034065037.1|1|1|tmexD3|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD3|AMR|tetracycline	24.2	1051	1048	1044	4.17e-59	219
k141_23717_3	SARG|gi|489273629|ref|WP_003181339.1|	24.0	1039	1048	1059	4.50e-59	219
k141_23717_3	SARG|gi|1011729993|ref|WP_062573631.1|	24.3	1034	1048	1042	5.51e-59	219
k141_23717_3	ResF|tmexD3_1_LC633285_1	24.2	1051	1048	1044	7.43e-59	219
k141_23717_3	SARG|YP_371056	22.2	1030	1048	1066	1.11e-58	218
k141_229429_1	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	27.2	694	650	1024	8.53e-62	221
k141_229429_1	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	27.2	694	650	1024	8.53e-62	221
k141_229429_1	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	27.2	694	650	1024	8.53e-62	221
k141_229429_1	SARG|gb|CAA53189|ARO:3000521|mupA	27.2	694	650	1024	8.53e-62	221
k141_229429_1	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	25.8	507	650	1033	7.12e-45	171
k141_229429_1	SARG|gb|AEY83581|ARO:3000510|mupB	25.8	507	650	1033	7.12e-45	171
k141_524748_5	NCBI|WP_000052512.1|1|1|msr(E)|msr(E)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(E)|AMR|multidrug	50.0	70	171	491	4.18e-17	76.6
k141_524748_5	NCBI|WP_000420313.1|1|1|msr(D)|msr(D)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(D)|AMR|multidrug	48.6	70	171	487	2.65e-16	74.3
k141_524748_5	NCBI|WP_000420317.1|1|1|msr(D)|msr(D)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(D)|AMR|multidrug	48.6	70	171	487	2.65e-16	74.3
k141_524748_5	SARG|gb|APB03219.1|ARO:3003986|TaeA	49.3	75	171	648	3.90e-16	73.9
k141_524748_5	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	44.3	70	171	655	3.91e-16	73.9
k141_524748_5	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	44.3	70	171	655	3.91e-16	73.9
k141_524748_5	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	42.9	70	171	655	1.34e-15	72.4
k141_524748_5	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	42.9	70	171	655	1.34e-15	72.4
k141_524748_5	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	42.9	70	171	655	1.34e-15	72.4
k141_524748_5	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	42.9	70	171	655	1.34e-15	72.4
k141_435189_2	SARG|gi|487135433|ref|WP_001627390.1|	27.9	154	368	388	7.24e-10	58.9
k141_435189_2	SARG|gi|1005595863|ref|WP_061683938.1|	27.9	154	368	388	7.24e-10	58.9
k141_435189_2	SARG|gi|686319989|ref|WP_031875473.1|	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|gi|920597324|ref|WP_053012334.1|	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|gi|686393404|ref|WP_031907214.1|	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|YP_001246098	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|gi|686370148|ref|WP_031895695.1|	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|gi|1006171094|ref|WP_061738168.1|	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|gi|686390434|ref|WP_031905541.1|	27.9	154	368	388	1.71e-09	57.8
k141_435189_2	SARG|gi|686115864|ref|WP_031765718.1|	27.3	154	368	388	2.28e-09	57.4
k141_700371_1	SARG|YP_002850805	27.0	141	640	652	3.07e-12	68.6
k141_700371_1	SARG|ZP_02952732	27.7	141	640	652	5.33e-12	67.8
k141_700371_1	SARG|L20800.gene.p01	27.7	141	640	652	5.33e-12	67.8
k141_700371_1	SARG|ZP_02632674	27.7	141	640	660	5.38e-12	67.8
k141_362762_2	SARG|NC_010410.6003348.p01	35.5	107	108	109	5.44e-20	77.0
k141_362762_2	SARG|gb|AEH26330.1|ARO:3005009|qacE	38.4	99	108	110	3.62e-18	72.4
k141_362762_2	SARG|P23895	35.4	99	108	110	8.22e-17	68.9
k141_362762_2	SARG|gi|643599925|ref|WP_025237077.1|	35.4	99	108	110	1.16e-16	68.6
k141_362762_2	SARG|NC_002695.1.913273.p01	35.4	99	108	110	1.16e-16	68.6
k141_362762_2	SARG|ZP_03048536	35.4	99	108	110	1.16e-16	68.6
k141_362762_2	SARG|ZP_04003442	35.4	99	108	117	1.38e-16	68.6
k141_362762_2	SARG|gi|116668015|pdb|2I68|A	35.4	99	108	137	1.56e-16	68.9
k141_362762_2	SARG|gb|AAC44316.1|ARO:3005010|qacEdelta1	39.4	99	108	115	2.63e-16	67.8
k141_362762_2	SARG|ABG69871	35.4	99	108	165	4.01e-16	68.6
k141_289090_4	SARG|gb|AAA26793|ARO:3003748|oleC	32.5	169	206	325	1.90e-26	102
k141_289090_4	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	32.5	169	206	325	1.90e-26	102
k141_289090_4	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	32.5	166	206	343	4.78e-26	101
k141_289090_4	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	30.8	172	206	293	6.16e-25	97.8
k141_289090_4	SARG|gb|AAR96051.1|ARO:3002894|otrC	33.3	132	206	351	2.51e-21	89.0
k141_289090_4	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	32.8	131	206	351	1.26e-20	87.0
k141_289090_4	SARG|gb|CDO61516.1|ARO:3003949|efrB	32.2	118	206	362	2.70e-07	48.9
k141_230070_2	SARG|gi|696368937|ref|WP_032943949.1|	39.9	228	251	648	2.66e-42	151
k141_230070_2	SARG|gi|851913025|ref|WP_048215946.1|	40.1	227	251	648	3.66e-42	150
k141_230070_2	SARG|gi|696361545|ref|WP_032936694.1|	39.9	228	251	648	3.66e-42	150
k141_230070_2	SARG|gi|489930965|ref|WP_003834285.1|	40.1	227	251	648	3.66e-42	150
k141_230070_2	SARG|YP_002850060	40.1	227	251	648	5.05e-42	150
k141_230070_2	SARG|gi|489936909|ref|WP_003840216.1|	40.1	227	251	648	5.05e-42	150
k141_230070_2	SARG|gi|507079862|ref|WP_016150620.1|	40.1	227	251	648	5.05e-42	150
k141_230070_2	SARG|gi|949791377|ref|WP_057104572.1|	40.1	227	251	648	5.05e-42	150
k141_230070_2	SARG|gi|936194420|ref|WP_054528571.1|	40.1	227	251	648	1.32e-41	149
k141_230070_2	SARG|gi|851922185|ref|WP_048218206.1|	40.1	227	251	648	1.32e-41	149
k141_127929_4	SARG|gb|BAI83385.1|ARO:3003440|mecB	27.7	535	623	674	3.76e-39	152
k141_127929_4	NCBI|WP_063852710.1|1|1|mecB|mecB|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecB|AMR|beta-lactam	27.1	535	623	674	5.56e-38	148
k141_127929_4	SARG|gb|AQX82857.1|ARO:3004185|mecD	24.5	563	623	678	3.64e-36	143
k141_127929_4	NCBI|WP_049151672.1|1|1|pbp2m|pbp2m||2|beta-lactam|beta-lactam|penicillin-binding_protein_PBP2M|AMR|beta-lactam	26.0	365	623	593	3.28e-19	90.5
k141_333512_1	megares|MEG_1246|Drugs|beta-lactam|Class_A_betalactamases|BLAA_1	36.2	276	291	339	5.70e-60	193
k141_333512_2	SARG|Q52360	25.3	498	607	641	3.43e-27	115
k141_333512_2	NCBI|WP_063856408.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	25.1	498	607	654	3.58e-27	115
k141_333512_2	megares|MEG_7182|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	25.1	498	607	670	3.76e-27	115
k141_333512_2	SARG|AAB51122	25.1	498	607	670	3.76e-27	115
k141_333512_2	SARG|P70882	25.3	498	607	641	4.56e-27	115
k141_333512_2	SARG|BAD46890	25.3	498	607	657	4.81e-27	115
k141_333512_2	SARG|Q08425	24.9	498	607	641	6.08e-27	114
k141_333512_2	megares|MEG_7181|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	24.9	498	607	657	6.41e-27	114
k141_333512_2	SARG|Z21523.gene.p01	24.9	498	607	657	6.41e-27	114
k141_333512_2	NCBI|WP_063856409.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	25.2	497	607	641	1.08e-26	114
k141_156995_2	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	32.6	181	351	397	1.62e-21	93.6
k141_246110_7	SARG|gb|ADZ12699.1|ARO:3005091|RanA	33.9	242	246	258	1.11e-41	142
k141_246110_7	SARG|gi|736472622|ref|WP_034494292.1|	38.9	221	246	648	1.60e-37	137
k141_246110_7	SARG|gi|1035670474|ref|WP_064517458.1|	37.6	237	246	648	3.01e-37	137
k141_246110_7	SARG|gi|1035717981|ref|WP_064557480.1|	37.6	237	246	648	3.01e-37	137
k141_246110_7	SARG|gb|WP_082039181.1|ARO:3007028|salD	27.0	204	246	544	1.38e-14	71.6
k141_246110_7	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	26.6	199	246	528	1.54e-09	56.6
k141_40677_2	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	32.2	245	315	355	3.05e-26	105
k141_40677_2	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	32.2	245	315	355	3.05e-26	105
k141_40677_2	SARG|ACM47285	32.2	245	315	363	3.41e-26	105
k141_40677_2	megares|MEG_7603|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	31.5	251	315	355	1.11e-25	103
k141_40677_2	SARG|BAE96115	31.5	251	315	355	1.11e-25	103
k141_526453_1	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	36.1	255	249	323	1.67e-44	151
k141_526453_1	SARG|DQ018711.1.gene4.p01	35.1	259	249	322	2.49e-43	148
k141_526453_1	SARG|gi|738848198|ref|WP_036737307.1|	34.9	261	249	323	1.08e-41	144
k141_526453_1	SARG|YP_002333394	35.9	251	249	323	1.08e-41	144
k141_526453_1	SARG|gi|552942232|ref|WP_023043160.1|	34.6	254	249	323	2.13e-41	143
k141_526453_1	SARG|gi|737310392|ref|WP_035293250.1|	34.4	259	249	323	2.13e-41	143
k141_526453_1	SARG|AF310956.2.gene5.p01	35.5	251	249	323	4.21e-41	142
k141_526453_1	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	35.5	251	249	323	4.21e-41	142
k141_526453_1	SARG|AY082011.1.gene6.p01	34.3	254	249	323	1.64e-40	140
k141_526453_1	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	33.2	253	249	314	5.20e-40	139
k141_452380_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	33.0	215	263	255	6.77e-25	98.6
k141_452380_2	SARG|gb|ABX00624.1|ARO:3002881|lmrC	34.7	190	263	550	1.65e-12	65.9
k141_452380_2	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.6	225	263	655	5.37e-07	49.3
k141_452380_2	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.6	225	263	655	5.37e-07	49.3
k141_452380_2	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.1	225	263	655	4.07e-06	46.6
k141_673294_1	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	34.1	164	364	411	1.87e-22	96.7
k141_673294_1	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	34.1	164	364	411	1.87e-22	96.7
k141_673294_1	SARG|gi|695688999|ref|WP_032634100.1|	35.1	148	364	404	2.06e-21	93.6
k141_673294_1	SARG|gi|735677397|ref|WP_034167813.1|	33.3	162	364	404	2.79e-21	93.2
k141_673294_1	NCBI|WP_061345584.1|1|1|cml_Ochro|cml_Ochro|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	35.8	148	364	397	3.58e-21	92.8
k141_673294_1	SARG|gi|742921897|ref|WP_039023559.1|	33.3	162	364	404	3.79e-21	92.8
k141_673294_1	SARG|gi|730661043|ref|WP_034065992.1|	32.9	164	364	404	3.79e-21	92.8
k141_673294_1	SARG|gi|1028086691|ref|WP_063845065.1|	33.3	162	364	404	3.79e-21	92.8
k141_673294_1	SARG|gi|499772320|ref|WP_011453054.1|	33.3	162	364	404	3.79e-21	92.8
k141_673294_1	SARG|AJ518835.1.gene6.p01	33.3	162	364	404	3.79e-21	92.8
k141_378551_1	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	39.3	145	148	228	1.85e-31	111
k141_378551_1	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	44.2	120	148	252	1.26e-30	109
k141_378551_1	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	39.9	148	148	231	6.17e-30	107
k141_378551_1	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	40.5	148	148	232	2.49e-29	105
k141_378551_1	CARD|gb|AAD51348.1|ARO:3003066|smeR	39.2	120	148	229	3.92e-23	89.7
k141_378551_1	CARD|gb|AAC73788.1|ARO:3003841|kdpE	37.8	148	148	225	1.41e-22	88.2
k141_378551_1	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	37.9	145	148	225	1.98e-22	87.8
k141_378551_1	CARD|gb|AAG05188.1|ARO:3005068|ParR	34.1	138	148	235	2.40e-22	87.8
k141_378551_1	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	36.4	118	148	233	3.06e-16	71.6
k141_496599_2	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	29.2	226	241	343	6.34e-25	99.8
k141_496599_2	SARG|gi|817122037|ref|WP_046494699.1|	25.8	229	241	613	3.93e-15	73.2
k141_496599_2	SARG|gb|AAC74000.1|ARO:3003950|msbA	26.8	235	241	582	5.20e-15	72.8
k141_496599_2	SARG|gi|748767925|ref|WP_040019608.1|	26.1	226	241	623	7.21e-15	72.4
k141_496599_2	SARG|gi|1045390184|ref|WP_065479071.1|	24.8	238	241	605	2.38e-14	70.9
k141_496599_2	SARG|gi|948137056|ref|WP_056795395.1|	25.4	224	241	602	1.94e-13	68.2
k141_496599_2	SARG|gi|497748188|ref|WP_010062372.1|	24.4	238	241	605	1.95e-13	68.2
k141_496599_2	SARG|gi|764446018|ref|WP_044369325.1|	23.9	238	241	605	2.63e-13	67.8
k141_496599_2	SARG|gi|662129758|ref|WP_030081404.1|	24.8	238	241	605	2.63e-13	67.8
k141_496599_2	SARG|gi|664085850|ref|WP_030624018.1|	24.8	238	241	605	3.55e-13	67.4
k141_570410_1	SARG|gi|553774750|ref|WP_023106587.1|	31.0	258	331	472	1.29e-27	111
k141_570410_1	SARG|gi|686099038|ref|WP_031755887.1|	31.0	258	331	472	1.29e-27	111
k141_570410_1	SARG|gi|685898668|ref|WP_031639304.1|	31.0	258	331	472	1.29e-27	111
k141_570410_1	SARG|gi|553765230|ref|WP_023097551.1|	31.0	258	331	472	1.29e-27	111
k141_570410_1	SARG|YP_790742	31.0	258	331	472	1.76e-27	110
k141_570410_1	SARG|gi|553755604|ref|WP_023088332.1|	31.0	258	331	472	1.76e-27	110
k141_570410_1	SARG|gi|685983084|ref|WP_031690280.1|	31.0	258	331	472	1.76e-27	110
k141_570410_1	SARG|gi|504415764|ref|WP_014602866.1|	31.0	258	331	472	1.76e-27	110
k141_570410_1	SARG|gi|553756495|ref|WP_023089177.1|	31.0	258	331	472	1.76e-27	110
k141_570410_1	SARG|NC_002516.2.882885.p01	31.0	258	331	472	1.76e-27	110
k141_276814_2	SARG|gb|ADZ12699.1|ARO:3005091|RanA	31.8	217	264	258	4.12e-31	115
k141_276814_2	SARG|gi|542061059|gb|ERI11611.1|	27.8	216	264	316	7.49e-25	99.8
k141_276814_2	SARG|gi|895865878|ref|WP_048974758.1|	32.1	212	264	646	3.49e-23	97.4
k141_42175_1	SARG|gb|ADZ12699.1|ARO:3005091|RanA	37.9	206	248	258	6.34e-48	158
k141_42175_1	SARG|gi|542061059|gb|ERI11611.1|	29.8	228	248	316	7.37e-35	125
k141_42175_1	SARG|gi|500194536|ref|WP_011867743.1|	29.4	228	248	306	3.42e-33	121
k141_42175_1	SARG|gi|507023808|ref|WP_016095885.1|	29.1	220	248	309	7.12e-33	120
k141_42175_1	SARG|gi|507035724|ref|WP_016107411.1|	28.3	223	248	309	1.95e-32	119
k141_42175_1	SARG|gi|445996695|ref|WP_000074550.1|	28.7	223	248	309	1.95e-32	119
k141_42175_1	SARG|gi|507044560|ref|WP_016115614.1|	29.0	231	248	306	2.57e-32	119
k141_42175_1	SARG|gi|488053456|ref|WP_002124853.1|	28.6	220	248	309	2.73e-32	119
k141_42175_1	SARG|gi|445996697|ref|WP_000074552.1|	28.3	223	248	309	2.73e-32	119
k141_42175_1	SARG|gi|447057510|ref|WP_001134766.1|	28.6	220	248	309	2.73e-32	119
k141_291348_1	SARG|gb|ADZ12699.1|ARO:3005091|RanA	38.0	100	126	258	8.05e-15	67.4
k141_394459_3	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	33.2	211	226	231	1.80e-29	108
k141_394459_3	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	31.6	212	226	231	1.93e-28	106
k141_394459_3	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	33.2	211	226	231	5.34e-28	105
k141_394459_3	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	31.1	212	226	231	1.05e-27	104
k141_394459_3	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	31.1	212	226	231	1.48e-27	103
k141_394459_3	CARD|gb|AAG06465.1|ARO:3005063|cprR	31.6	196	226	223	2.42e-27	103
k141_394459_3	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	30.8	208	226	232	2.97e-27	103
k141_394459_3	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	30.8	208	226	232	2.97e-27	103
k141_394459_3	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	30.1	206	226	230	1.10e-26	101
k141_394459_3	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	30.8	201	226	233	1.17e-26	101
k141_394459_4	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	27.9	219	428	447	9.56e-14	71.6
k141_306264_3	SARG|gb|AAC75089.1|ARO:3003577|ugd	56.1	394	395	388	1.96e-163	462
k141_615202_3	SARG|gi|950488344|ref|WP_057382159.1|	35.2	108	366	370	2.73e-06	47.8
k141_615202_3	SARG|gi|959949565|ref|WP_058201997.1|	35.2	108	366	351	3.47e-06	47.4
k141_615202_3	SARG|gi|920589277|ref|WP_053008119.1|	35.2	108	366	351	3.47e-06	47.4
k141_615202_3	SARG|gi|921019590|ref|WP_053065897.1|	35.2	108	366	351	3.47e-06	47.4
k141_615202_3	SARG|gi|959846819|ref|WP_058132783.1|	35.2	108	366	355	3.51e-06	47.4
k141_615202_3	SARG|gi|959919282|ref|WP_058180786.1|	35.2	108	366	356	3.51e-06	47.4
k141_615202_3	SARG|gi|959851852|ref|WP_058135766.1|	35.2	108	366	361	3.56e-06	47.4
k141_615202_3	SARG|gi|890840499|ref|WP_048909895.1|	35.2	108	366	361	3.56e-06	47.4
k141_615202_3	SARG|gi|959845233|ref|WP_058132030.1|	35.2	108	366	363	3.57e-06	47.4
k141_615202_3	SARG|gi|759819555|ref|WP_043515826.1|	35.2	108	366	366	3.60e-06	47.4
k141_615202_4	SARG|AAN28721	41.9	74	224	108	3.35e-13	62.8
k141_543055_1	megares|MEG_1756|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	25.7	335	404	419	1.53e-06	48.9
k141_543055_1	NCBI|WP_071846197.1|1|1|cmlA|cmlA|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA_family_phenicol_efflux_MFS_transporter|AMR|phenicol	25.7	335	404	419	1.53e-06	48.9
k141_543055_1	SARG|gi|446289936|ref|WP_000367791.1|	25.4	335	404	390	1.92e-06	48.5
k141_543055_1	megares|MEG_1770|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	25.4	335	404	390	1.92e-06	48.5
k141_543055_1	SARG|AF458080.1.gene3.p01	25.4	335	404	419	2.03e-06	48.5
k141_543055_1	megares|MEG_1761|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	25.4	335	404	419	2.03e-06	48.5
k141_543055_1	NCBI|WP_071846279.1|1|1|cmlA|cmlA|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA_family_phenicol_efflux_MFS_transporter|AMR|phenicol	25.4	335	404	419	2.03e-06	48.5
k141_543055_1	megares|MEG_1760|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	25.4	335	404	419	2.03e-06	48.5
k141_543055_1	megares|MEG_1766|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	25.4	335	404	419	2.03e-06	48.5
k141_543055_1	SARG|gb|ABW91179.1|ARO:3004665|cmlA8	26.0	335	404	419	2.03e-06	48.5
k141_14097_2	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.2	520	526	655	1.04e-94	300
k141_14097_2	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.2	520	526	655	1.04e-94	300
k141_14097_2	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	1.46e-94	300
k141_14097_2	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	2.05e-94	300
k141_14097_2	SARG|gb|AKA86814|ARO:3003746|optrA	34.0	520	526	655	2.05e-94	300
k141_14097_2	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	7.97e-94	298
k141_14097_2	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	1.57e-93	297
k141_14097_2	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	1.57e-93	297
k141_14097_2	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	1.57e-93	297
k141_14097_2	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.0	520	526	655	1.57e-93	297
k141_71625_6	CARD|gb|CAA79966.1|ARO:3003665|NmcR	39.3	56	308	295	3.79e-06	46.6
k141_233941_1	NCBI|AAN29241.1|1|1|bepE|bepE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepE|AMR|efflux	43.4	1046	1061	1051	3.08e-263	767
k141_233941_1	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	42.3	1047	1061	1074	2.00e-258	756
k141_233941_1	SARG|gi|489327637|ref|WP_003234928.1|	41.9	1072	1061	1059	1.40e-254	745
k141_233941_1	SARG|CAY49157	41.9	1072	1061	1059	1.40e-254	745
k141_233941_1	SARG|gi|780147796|ref|WP_045491627.1|	41.6	1050	1061	1063	1.58e-254	745
k141_233941_1	SARG|gi|1044868049|dbj|BAV27457.1|	41.4	1074	1061	1058	1.91e-254	745
k141_233941_1	SARG|gi|504907940|ref|WP_015095042.1|	42.0	1054	1061	1059	1.97e-254	745
k141_233941_1	SARG|gi|803453816|ref|WP_046068030.1|	41.7	1072	1061	1059	2.78e-254	744
k141_233941_1	SARG|gi|496334960|ref|WP_009044138.1|	41.9	1060	1061	1059	2.78e-254	744
k141_233941_1	SARG|gi|497896441|ref|WP_010210597.1|	42.0	1072	1061	1059	3.93e-254	744
k141_233941_2	SARG|gi|817658374|ref|WP_046623773.1|	33.8	225	271	396	1.15e-33	125
k141_233941_2	SARG|gi|880831881|ref|WP_048668149.1|	35.0	226	271	397	1.63e-33	124
k141_233941_2	SARG|ZP_02656523	35.0	226	271	397	1.63e-33	124
k141_233941_2	SARG|gi|912530277|ref|WP_050177011.1|	35.0	226	271	397	1.63e-33	124
k141_233941_2	SARG|gi|912606377|ref|WP_050194910.1|	35.0	226	271	397	1.63e-33	124
k141_233941_2	SARG|gi|445932785|ref|WP_000010640.1|	35.8	212	271	406	1.87e-33	124
k141_233941_2	SARG|gi|817604003|ref|WP_046597369.1|	34.4	227	271	397	3.15e-33	124
k141_233941_2	SARG|CAR60299	34.5	226	271	397	3.15e-33	124
k141_233941_2	SARG|gi|518286938|ref|WP_019457146.1|	34.9	212	271	406	3.61e-33	124
k141_233941_2	SARG|NP_459471	34.5	226	271	397	4.39e-33	123
k141_630409_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	32.3	195	196	255	8.01e-27	101
k141_630409_2	SARG|gi|823326845|ref|WP_047080664.1|	38.9	193	196	648	7.60e-26	102
k141_630409_2	SARG|gi|823302270|ref|WP_047057473.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|976146774|ref|WP_059305359.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|1022664304|ref|WP_063420886.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|823309640|ref|WP_047064288.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|505807117|ref|WP_015704872.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|518923394|ref|WP_020079269.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|695797094|ref|WP_032711285.1|	38.9	193	196	648	1.41e-25	102
k141_630409_2	SARG|gi|823299155|ref|WP_047054544.1|	38.9	193	196	648	1.41e-25	102
k141_234042_1	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	44.0	200	346	255	1.05e-53	176
k141_234042_1	SARG|gi|542061059|gb|ERI11611.1|	36.7	218	346	316	1.26e-41	146
k141_234042_1	SARG|gi|447195835|ref|WP_001273091.1|	35.8	218	346	306	2.17e-39	140
k141_234042_1	SARG|ZP_04081918	35.8	218	346	306	2.17e-39	140
k141_234042_1	SARG|gi|507044560|ref|WP_016115614.1|	35.8	218	346	306	3.03e-39	140
k141_234042_1	SARG|gi|488068784|ref|WP_002140181.1|	35.3	221	346	309	3.25e-39	140
k141_234042_1	SARG|gi|447057510|ref|WP_001134766.1|	34.8	221	346	309	4.55e-39	139
k141_234042_1	SARG|gi|447195836|ref|WP_001273092.1|	35.3	218	346	306	5.93e-39	139
k141_234042_1	SARG|gi|507055561|ref|WP_016126482.1|	34.8	221	346	309	6.36e-39	139
k141_234042_1	SARG|gi|488053456|ref|WP_002124853.1|	34.8	221	346	309	6.36e-39	139
k141_337027_3	CARD|gb|ABV18113.1|ARO:3001329|mdtG	30.7	375	382	408	5.08e-53	180
k141_337027_3	SARG|WP_000136147.1	29.8	369	382	399	4.27e-45	159
k141_337027_3	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	27.4	369	382	371	1.01e-33	127
k141_249165_3	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	42.2	232	230	233	1.48e-55	176
k141_249165_3	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	40.5	227	230	231	2.79e-55	175
k141_249165_3	NCBI|WP_063856722.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	41.8	232	230	232	4.06e-55	175
k141_249165_3	NCBI|WP_063856715.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	42.7	232	230	232	5.75e-55	174
k141_249165_3	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.2	227	230	231	1.58e-54	173
k141_249165_3	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.2	227	230	231	4.48e-54	172
k141_249165_3	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.2	227	230	231	6.33e-54	172
k141_249165_3	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	230	230	231	1.79e-53	171
k141_249165_3	NCBI|WP_023043165.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	41.8	232	230	232	1.85e-53	171
k141_249165_3	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	41.4	232	230	232	1.85e-53	171
k141_249165_4	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	26.7	307	499	365	8.16e-30	119
k141_249165_4	CARD|gb|CYF42523.1|ARO:3004047|kdpD	24.8	218	499	885	1.18e-11	66.2
k141_160307_1	SARG|gb|BAE06006.1|ARO:3003705|mexN	25.3	479	501	1036	1.20e-36	143
k141_160307_1	SARG|YP_001350280	25.8	503	501	1018	5.77e-34	135
k141_160307_1	SARG|YP_792720	25.7	494	501	1018	1.87e-33	134
k141_160307_1	SARG|AAG07763	25.7	494	501	1018	1.87e-33	134
k141_160307_1	SARG|gb|AAL19305.1|ARO:3000790|mdsB	25.6	481	501	1055	2.79e-31	127
k141_160307_1	SARG|gi|780147796|ref|WP_045491627.1|	25.1	505	501	1063	9.00e-31	125
k141_160307_1	SARG|gi|491017944|ref|WP_004879650.1|	25.3	505	501	1063	9.00e-31	125
k141_160307_1	SARG|gi|489273629|ref|WP_003181339.1|	25.9	498	501	1059	1.61e-30	125
k141_160307_1	SARG|gi|764388704|ref|WP_044345422.1|	25.0	503	501	1061	1.61e-30	125
k141_160307_1	SARG|gi|803453816|ref|WP_046068030.1|	24.8	500	501	1059	2.16e-30	124
k141_57814_1	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	45.3	53	64	397	4.31e-09	49.3
k141_249722_4	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	44.5	677	650	703	1.26e-180	528
k141_308147_1	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	31.2	706	721	1024	1.36e-102	336
k141_308147_1	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	31.2	706	721	1024	1.36e-102	336
k141_308147_1	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	31.2	706	721	1024	1.36e-102	336
k141_308147_1	SARG|gb|CAA53189|ARO:3000521|mupA	31.2	706	721	1024	1.36e-102	336
k141_337990_4	NCBI|WP_005480402.1|1|1|tet(35)|tet(35)|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_Na+/H+_antiporter_family_transporter_Tet(35)|AMR|tetracycline	38.6	495	500	533	9.83e-90	283
k141_337990_4	SARG|AF353562.gene.p01	34.3	373	500	369	2.45e-51	177
